ada.enesco, Author at European Medical Journal - Page 41 of 66

Risk Factors for Inadequate Bowel Preparation Before Colonoscopy

A comprehensive meta-analysis has identified key risk factors associated with inadequate bowel preparation before colonoscopy.

New Psoriasis Antibody Treatment Shows Exceptional Clinical Results

Across both trial phases, adverse events were primarily mild to moderate, with no drug-related serious incidents reported.

Triple Single-Pill Lowers Blood Pressure Safely in Clinical Trial

New triple single-pill treatment lowers BP effectively and safely, simplifying early hypertension management in clinical practice.

Long-Term Benefits of MRI-Guided Stereotactic Body Radiotherapy

Logistic regression analysis revealed that patients receiving MRI-guided stereotactic body radiotherapy had significantly lower odds of experiencing clinically relevant deterioration.

GLI Criteria Reduce COPD Misclassification in Older Smokers

GLI spirometry criteria reduce COPD misclassification in older smokers, ensuring accurate diagnosis and preventing unnecessary treatments.

PET Imaging Technique Identifies Early Graft-Versus-Host Disease

New imaging technique able to identify early signs of graft-versus-host-disease in transplant patients.

Landmark Trial Confirms Superiority of TAVI-PCI in Severe Aortic Stenosis and Coronary Disease

PCI plus TAVI offers superior outcomes over SAVR plus CABG for severe aortic stenosis and complex CAD.

Early Oseltamivir Treatment Reduces Mortality in Patients Hospitalized with Flu

Initiating oseltamivir treatment on the day of hospital admission significantly reduces the severity of illness and risk of death in adults hospitalized with influenza.

New Study Identifies Potential Target for Treating Diabetic Cardiomyopathy

Promising therapeutic target for diabetic cardiomyopathy found.

Immunoglobulin E Levels Cannot Predict Atopic Dermatitis Severity

Elevated total immunoglobulin E levels are associated with atopic dermatitis, but IgE levels cannot reliably evaluate AD severity.